Fatigue in Inflammatory Joint Diseases

被引:5
|
作者
Chmielewski, Grzegorz [1 ]
Majewski, Michal S. [2 ]
Kuna, Jakub [1 ]
Mikiewicz, Mateusz [3 ]
Krajewska-Wlodarczyk, Magdalena [1 ]
机构
[1] Univ Warmia & Mazury, Sch Med, Dept Rheumatol, Coll Medicum, PL-10900 Olsztyn, Poland
[2] Univ Warmia & Mazury, Fac Med, Dept Pharmacol & Toxicol, PL-10082 Olsztyn, Poland
[3] Univ Warmia & Mazury, Fac Vet Med, Dept Pathol Anat, PL-10719 Olsztyn, Poland
关键词
fatigue; inflammation; cytokines; inflammatory joint diseases; INTERLEUKIN-6 RECEPTOR INHIBITION; RHEUMATOLOGY BIOLOGICS REGISTER; ANKYLOSING-SPONDYLITIS; PSORIATIC-ARTHRITIS; SICKNESS BEHAVIOR; BRITISH SOCIETY; SERUM-LEVELS; DOPAMINE; THERAPY; ALPHA;
D O I
10.3390/ijms241512040
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Fatigue is a prevalent symptom in various rheumatic diseases, such as rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. It is characterised as a subjective, enduring feeling of generalised tiredness or exhaustion, impacting the patient's life quality and exacerbating disability. The fatigue nature is multifaceted, encompassing physiological, psychological, and social factors, and although the exact cause of inflammatory joint diseases is not fully understood, several factors are believed to contribute to its development. Despite high prevalence and importance, the symptom is often underestimated in clinical practice. Chronic inflammation, commonly associated with rheumatic diseases, has been proposed as a potential contributor to fatigue development. While current treatments effectively target inflammation and reduce disease activity, fatigue remains a persistent problem. Clinical evaluation of rheumatic diseases primarily relies on objective criteria, whereas fatigue, being a subjective symptom, is solely experienced and reported by the patient. Managing fatigue in inflammatory joint diseases involves a multifaceted approach. Identifying and comprehensively assessing the subjective components of fatigue in individual patients is crucial for effectively managing this symptom in everyday clinical practice.
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Role of MicroRNAs in Inflammatory Joint Diseases: A Review
    Syed, Nazmul Huda
    Mussa, Ali
    Elmi, Abdirahman Hussein
    Al-Khreisat, Mutaz Jamal
    Zain, Muhammad Rajaei Ahmad Mohd
    Nurul, Asma Abdullah
    IMMUNOLOGICAL INVESTIGATIONS, 2024, 53 (02) : 185 - 209
  • [2] Potential Mechanism of Fatigue Induction and Its Management by JAK Inhibitors in Inflammatory Rheumatic Diseases
    Felis-Giemza, Anna
    Massalska, Magdalena
    Roszkowski, Leszek
    Romanowska-Prochnicka, Katarzyna
    Ciechomska, Marzena
    JOURNAL OF INFLAMMATION RESEARCH, 2023, 16 : 3949 - 3965
  • [3] Peripheral and Central Mechanisms of Fatigue in Inflammatory and Noninflammatory Rheumatic Diseases
    Staud, Roland
    CURRENT RHEUMATOLOGY REPORTS, 2012, 14 (06) : 539 - 548
  • [4] Persistence of remission after lengthening of golimumab in inflammatory joint diseases
    Damiani, Arianna
    Bartoli, Francesca
    Pacini, Giovanni
    Carboni, Davide
    Randone, Silvia Bellando
    Fiori, Ginevra
    Matucci-Cerinic, Marco
    Guiducci, Serena
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2023, 41 (05) : 1088 - 1095
  • [5] Unmet needs in the management of cardiovascular risk in inflammatory joint diseases
    Castaneda, Santos
    Vicente-Rabaneda, Esther F.
    Garcia-Castaneda, Noelia
    Prieto-Pena, Diana
    Dessein, Patrick H.
    Gonzalez-Gay, Miguel A.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2020, 16 (01) : 23 - 36
  • [6] Sex and Cardiovascular Involvement in Inflammatory Joint Diseases
    Santos Castañeda
    Carlos González-Juanatey
    Miguel A. González-Gay
    Clinical Reviews in Allergy & Immunology, 2019, 56 : 278 - 292
  • [7] Pathophysiology of osteoporosis in chronic inflammatory joint diseases
    Castaneda, S.
    Garces-Puentes, M., V
    Pineda, Bernad M.
    REVISTA DE OSTEOPOROSIS Y METABOLISMO MINERAL, 2021, 13 (01) : 32 - 38
  • [8] Sex and Cardiovascular Involvement in Inflammatory Joint Diseases
    Castaneda, Santos
    Gonzalez-Juanatey, Carlos
    Gonzalez-Gay, Miguel A.
    CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2019, 56 (03) : 278 - 292
  • [9] Novel Therapeutic Strategies in Inflammatory Joint Diseases
    Benesova, Karolina
    Bender, Niko Kai
    Lorenz, Hanns-Martin
    AKTUELLE RHEUMATOLOGIE, 2018, 43 (02) : 161 - 168
  • [10] Osteoporosis in inflammatory joint diseases
    C. Roux
    Osteoporosis International, 2011, 22 : 421 - 433